Search

everythinglearnresearchcommunity

for

Search:↓

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Minoxidil and finasteride effectively treat hair loss.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Advanced human skin models improve drug development and could replace animal testing.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Skin problems are very common in people with end-stage kidney disease.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

Nanocrystals improve skin penetration and stability of caffeine, suggesting a new method for delivering similar substances through the skin.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Human skin cells can create new hair follicles when transplanted into mice.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.